The Take-Home Points

  • Vaginal estrogen prevents recurrent UTIs. The landmark 1993 NEJM trial proved it in postmenopausal women, and 30+ years of evidence has followed. Yet it’s still underused.

  • 75 to 89% fewer urinary symptoms. A 2025 meta-analysis of 17 RCTs and 2,111 patients found large reductions in urgency, leakage, and nighttime trips to the bathroom vs. placebo.

  • Low doses don’t meaningfully raise blood estrogen. Serum estradiol stays within the normal postmenopausal range (5 to 20 pg/mL).

    • In patients who are concerned about a rise in blood estrogen, I place them on vaginal estrogen and check an LC/MS estradiol (a much more accurate blood test) before and two months after starting the medication.

  • Systemic Hormone Replacement Therapy is not a substitute. 40 to 50% of women on oral HRT still report vaginal dryness, so they should also be using vaginal estrogen.

Watch the whiteboard explainer:

https://www.youtube.com/watch?v=i8NbuKNrAoI

Prefer to read? The full written issue is linked at the bottom. 👇

We’re redoing our best issues as short videos

A lot of you tell us the science lands faster when you can watch it drawn out on a whiteboard, so we’re remaking our most popular past issues as short video explainers.

You may have a mother, wife, or friend struggling with recurrent urinary tract infections. Send them the five-minute video. It’s worth knowing, and it gives them something concrete to bring to their physician.

Subscribe

Catch up on the rest of the series

Prefer the deep-dive? Read the original written issue here.

References

Raz & Stamm, N Engl J Med 1993 · Chen et al., Int Urogynecol J 2021 · Anger et al., J Urol 2022 · Porcari et al., Climacteric 2025 · Rahn et al., Obstet Gynecol 2014 · Pinkerton, N Engl J Med 2020 · Pinkerton et al., Clin Obstet Gynecol 2024 · Crandall et al., JAMA 2023 · ACOG Guideline 2019 · Mitchell et al., JAMA Netw Open 2022 · Mainar et al., Maturitas 2026 · Beste et al., Am J Obstet Gynecol 2025 · McVicker et al., JAMA Oncol 2024 · Clinical Consensus, Obstet Gynecol 2021 · Agrawal et al., Obstet Gynecol 2023 · Gompel & Simcock, Lancet Diabetes Endocrinol 2026 · Hickey et al., Lancet 2024 · NCCN Survivorship Guideline 2026 · NAMS Position Statement, Menopause 2020

Keep Reading